| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |